Pharmaceutical
[Summary] Consolidated Financial Results for the Three-Months Period of Fiscal 2026 (Three-Month Period Ended June 30, 2026) [JGAAP]
[Summary] Consolidated Financial Results for the Three-Months Period of Fiscal 2026 (Three-Month Period Ended June 30, 2026) [JGAAP]
![[Summary] Consolidated Financial Results for the Three-Months Period of Fiscal 2026 (Three-Month Period Ended June 30, 2026) [JGAAP]](https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d62144beedb30cb6fc2ac4.webp)
About this update from Kaken Pharmaceutical Co., Ltd.
Kaken Pharmaceutical Co., Ltd. (4521) Press ReleaseView Attachment
View stock analysis, news, and events for Kaken Pharmaceutical Co., Ltd.